Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles

SYDNEY--(BUSINESS WIRE)-- #Covid19--Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its Phase 1 CEP-2 sarcoma trial is underway with a first patient enrolled and dosed at City of Hope in Los Angeles, California. “We are delighted to have dosed the first patient in the CEP-2 trial,” said City of...

Click to view original post